The transactivator of transcription protein, HIV-1 Tat, is linked to neuroAIDS, where degeneration of dopamine neurons occurs. Using a mouse model expressing GFAP-driven Tat protein under doxycycline (Dox) regulation, we investigated microglial-neuronal interactions in the rostral substantia nigra pars compacta (SNc). Immunohistochemistry for microglia and tyrosine hydroxylase (TH) showed that the ratio of microglia to dopamine neurons is smaller in the SNc than in the ventral tegmental area (VTA) and that this difference is maintained following 7-day Dox exposure in wild type animals. Administration of Dox to wild types had no effect on microglial densities. In addressing the sensitivity of neurons to potentially adverse effects of HIV-1 Tat, we found that HIV-1 Tat exposure in vivo selectively decreased TH immunoreactivity in the SNc but not in the VTA, while levels of TH mRNA in the SNc remained unchanged. HIV-1 Tat induction in vivo did not alter the total number of neurons in these brain regions. Application of Tat (5 ng) into dopamine neurons with whole-cell patch pipette decreased spontaneous firing activity. Tat induction also produced a decline in microglial cell numbers, but no microglial activation. Thus, disappearance of dopaminergic phenotype is due to a loss of TH immunoreactivity rather than to neuronal death, which would have triggered microglial activation. We conclude that adverse effects of HIV-1 Tat produce a hypodopamine state by decreasing TH immunoreactivity and firing activity of dopamine neurons. Reduced microglial numbers after Tat exposure in vivo suggest impaired microglial functions and altered bidirectional interactions between dopamine neurons and microglia.
tegmental area (VTA; A10), and a third smaller cluster, found in the retrorubral area (A8; Bjorklund, & Dunnett, 2007; Fu et al., 2012; Nestler, Hyman, & Malenka, 2009; Zaborszky, & Vadasz, 2001) . Despite resembling each other in many respects, dopamine neurons of the SNc and VTA mediate distinct neurological functions and exhibit dissimilar responses to toxins and addictive agents (Choi et al., 2015; Macdonald & Monchi, 2011; Teo, van Wyk, Lin, & Lipski, 2004) . Since the discovery of dopamine as a neurotransmitter (Carlsson, Falck, & Hillarp, 1962) and the observation that it is depleted significantly in the SNc of patients with Parkinson's disease (Benazzouz et al., 2014; Hornykiewicz, & Kish, 1987; Tremblay et al., 2015) , the regionally selective vulnerability of dopamine neurons has been the focus of a large number of studies (Bernheimer et al., 1973; Braak & Braak, 1986; Braak et al., 2003; Burns et al., 1983; Damier, Hirsch, Agid, & Graybiel, 1999; Double, Reyes, Werry, & Halliday, 2010; Fearnley & Lees, 1991; German, Manaye, Sonsalla, & Brooks, 1992; Gibb & Lees, 1991; Greenfield & Bosanquet, 1953; Halliday & Tork, 1986; Hirsch, Graybiel, & Agid, 1989; Poulin et al., 2014) .
Microglia, which express D1 and D2 dopamine receptors (Farber, Pannasch, & Kettenmann, 2005) , have long been recognized as the primary and predominant CNS cell type to be productively infected by HIV-1 (Dickson et al., 1993; Garden, 2002; Michaels, Price, & Rosenblum, 1988) , and they are therefore of particular interest in terms of their mechanistic involvement with regard to dopamine dysregulation in the context of neuroAIDS. The primary purpose of the current study was to launch an in vivo investigation of possible interactions occurring between microglia and dopamine neurons, specifically in the context of HIV-1 infection.
To this end, we have utilized the GT-tg bigenic mouse, a transgenic model that expresses GFAP-driven Tat protein under Dox regulation in the CNS (Kim et al., 2003; Paris, Singh, Carey, & McLaughlin, 2015) .
Generally speaking, the interactions between microglia and CNS neurons are of significant research interest from a number of different perspectives under both normal and pathological conditions (BruceKeller, 1999; Eyo & Wu, 2013; Morgan et al., 2012; Pannell et al., 2014; Tsuda, Beggs, Salter, & Inoue, 2013) . Some ramified, nonactivated microglia present throughout the normal CNS can be observed making close contacts with all types of neurons, suggesting that molecular exchanges, for example, delivery of neurotrophins or synaptic remodeling, occur constitutively between them. Physical contacts and molecular interactions between microglia and neurons are intensified when damaged neurons trigger microglial activation (Streit, Walter, & Pennell, 1999; Virgone-Carlotta et al., 2013) . Such microglial activation represents the first phase of a neuroinflammatory response to injury and as such its purpose is to facilitate neuronal recovery/ regeneration, which occurs most conspicuously in neurons giving rise to peripheral nerves, and to a lesser extent in neurons whose axons are contained entirely within the CNS (Streit, 1993; Streit, Hurley, McGraw, & Semple-Rowland, 2000) . We therefore view microglia primarily as neuron-supporting and neuroprotective cells (Streit, 2002) .
Microglial interactions with dopamine neurons are largely unexplored but of great interest given the apparent susceptibility of these neurons to neurodegeneration, notably in the context of Parkinson's disease, but also with regard to other disorders such as addiction, schizophrenia, and attention deficit hyperactivity disorder and, of course, neuroAIDS (Barcia et al., 2012; Barcia et al., 2004; Barker, Root, Zhang, & Morales, 2016; Dalley et al., 2005; Hernandez et al., 2005; Hosp, Pekanovic, Rioult-Pedotti, & Luft, 2011; Kwak et al., 2012; Kwak et al., 2010; Molina-Luna et al., 2009; Navratilova et al., 2016; Nestler et al., 2009 ). Using the traditional biomarker tyrosine hydroxylase (TH, the rate-limiting enzyme for dopamine synthesis), we examined the ratio of microglia and dopamine neurons in the VTA and SNc before and after exposure to HIV-1 Tat, and then asked whether there is a correlation between this ratio in the SNc versus VTA and the differential sensitivity of these two neuronal populations to potentially adverse effects of HIV-1 Tat protein. Our data support the interpretation that interactions of microglia with dopaminergic neurons are an important link connecting dopaminergic dysfunction and NeuroHIV. These interactions could occur through direct effects of HIV-Tat on dopamine neurons or on microglia, as well as through indirect effects resulting from dopaminergic influence on microglial cell function or vice versa.
| M E T H O D S A N D M A T E R IA L S

| Animals and housing
Adult male GT-tg bigenic mice, RFP::TH mice (Lin, Sambo, & Khoshbouei, 2016; Richardson et al., 2016; Saha et al., 2014; Sambo et al., 2017) , and C57BL/6J wild-type (Jackson Labs, Bar Harbor, ME) mice (8-10 weeks of age) were maintained in the University of Florida animal facilities. All experiments were approved by the Institutional Animal Care and Use Committee. Creation of the GT-tg bigenic mice and genotype confirmation of the inducible and brain-targeted HIV-1 Tat protein was described previously (Kim et al., 2003; Paris et al., 2014) .
| Chemicals and reagents
All chemicals and reagents were obtained from Sigma-Aldrich (St Louis, MO). Doxycycline was dissolved in 0.9% saline before injection.
Recombinant HIV-1 Tat protein (Tat 1-86 ) was obtained from NIH AIDS Reagent Program.
| Induction of brain-targeted tat with doxycycline treatment
To express Tat 1-86 , GT-tg bigenic mice were administered doxycycline via intraperitoneal injections with a single daily dose of 100 mg/kg dissolved in 0.9% saline in a volume of 0.3 ml/30 g body weight for 7 days (GT-Dox), as indicated and characterized previously (Paris et al., 2014) .
Brains were harvested 7 days after Dox, or saline injections. GT-tg mice administered saline and C57BL/6J mice administered saline or doxycycline served as isogenic and congenic, negative controls, respectively. thickness with a vibratome. To ensure consistent comparisons only sections from similar coronal planes were used for quantitative image analysis ( Figure 1) . Two methods of analysis were used in this study: (a) image analysis using z-plane showing the highest intensity of staining (see below) and (b) stereological analysis. These analyses were performed in two separate animal cohorts. Substantia nigra sections were taken at a rostral point since degeneration in SNc is known to start rostrally (Gibb et al., 1991) . One section showing the full coronal orientation of SNc per animal was analyzed using quantitative image analysis described below.
One rostral and one central section of the VTA per animal was analyzed using the same quantitative image analysis. Each half of a reference section ( Figure 1 ) was analyzed individually and used as a separate data set.
In total, 4-5 animals per group were analyzed unless otherwise stated.
For anatomical distinction between SNc and VTA the Allen mouse brain reference atlas (Lein et al., 2007) and the characterization of dopaminergic areas in the mouse brain by (Fu et al., 2012) were used.
| Immunohistochemistry for quantitative image analysis
Free floating sections were blocked with 10% normal goat serum (NGS) in 0.1% Triton X-100 in PBS while incubated for 1 hr at 378C. Sections were then placed in primary antibody solution and kept at 48C overnight. Sections were washed in PBS three times for 20 min each.
The sections were incubated in secondary antibody solution at room temperature for 1 hr followed by an additional washing step. Sections were put on slides, air-dried and cover slipped with mounting medium (Fluoromount-G, Southern Biotech, Birmingham, AL) . Following addition of secondary antibody solution, sections were kept in the dark at all times. Antibodies were diluted with 5% NGS in 0.1 Triton X-100 in PBS.
The description of antibodies and their dilutions are provided in Table 1 .
| Image acquisition and background correction
All images were taken with a Nikon A1 confocal imaging system. Image analysis was performed with NIS-Elements version 4.5. Rolling ball reduction (rolling ball 5 50 pixels) was performed on all images to correct for uneven background staining. 
| NeuN area staining quantification
40 mm thick stacks with 5 mm step size images were acquired. Image stacks were then merged into a "Maximum Intensity Projection", projecting the brightest pixels throughout the stack into a single image. An ROI was defined by dense areas of TH1 neurons. The relative area of NeuN staining to the ROI size was measured by a custom pixel intensity thresholding macro in NIS-Elements Advanced Research analysis software to create a binary layer. A single intensity value determining the threshold was used for all images in each data set, adjusted when necessary.
| Tissue specimen and immunohistochemistry for stereology
A separate cohort of animals was prepared for stereological assessment. Brains were fixed as described above. Coronal sections of the entire midbrain were collected at 40 mm intervals. Free floating sections were washed in PBS and incubated in blocking solution containing 0.3% Triton X-100 and 10% NGS in PBS for 1 hr at 378C. Every other section of each brain was then incubated in primary antibody solutions containing rabbit anti-Iba1 (1:500); mouse anti-TH (1:400) or mouse anti-NeuN (1:500); rabbit anti-TH (1:500) overnight at 48C. Next, sections were washed with PBS and incubated in secondary antibody solutions containing 0.3% Triton X-100 and 5% NGS and Alexa Fluor 568 and 488-conjugated secondary antibodies for 1 hr at room temperature in the dark. After washing with PBS, sections were mounted, coverslipped, and stored until analyzed. 
| Stereological analysis
| Data analysis
All data were analyzed with Prism7 software. Shapiro-Wilk test was used to determine if the data is normally distributed. One-way ANOVA followed by post hoc Tukey honest significant different (HSD) test was used for comparison. Differences in the data were considered significant if p < .05. All values are presented as percent of control (relative to wild-type saline) mean 6 SEM. wild type mice treated with doxycycline (100 mg/kg) dissolved in 0.9% saline, and 6 GT-tg bigenic mice treated with doxycycline (100 mg/kg) dissolved in 0.9% saline) were mixed with TaqMan Gene Expression Assay primer sets for the genes, tyrosine hydroxylase (Th) and glyceraldehyde-3-phosphate dehydrogenase (Gapdh), which are listed in the below table, 23 TaqMan Universal PCR Master Mix (Applied Biosystems, Foster City, CA), and nuclease-free water. qPCR amplifications were performed in triplicate using the StepOne Real-Time PCR System (Thermofisher Scientific) at 508C for 2 min and 958C for 10 min, which was followed by 40 cycles of 958C for 15 s and 608C for 1 min. Gapdh was used as an internal control for normalization using the DDCt method. The relative changes in Th gene expression was analyzed using the 2(-DDCt) method (Livak & Schmittgen, 2001 ) and subsequent one-way ANOVA and Tukey post hoc tests from the data acquired from the real-time quantitative PCR experiments. Differences in the data were considered significant if p < .05.
| Mouse brain schematics
| Functional evaluation of dopamine neurons in vitro
Midbrain neuronal cultures were obtained from RFP::TH mice, a transgenic mouse strain where the dopamine neurons are rendered fluorescent (Lin et al., 2016; Richardson et al., 2016; Saha et al., 2014; Sambo et al., 2017) . Mouse midbrain dopamine neurons from 0 to 2-day-old pups of either sex were isolated and incubated in a dissociation medium at 348C-368C under continuous oxygenation for 2 hr.
Dissociated cells were pelleted by centrifugation at 500g for 10 min and resuspended in glial medium. Cells were plated on 12 mm round coverslips coated with 100 lg/ml poly-L-lysine and 5 lg/ml laminin in 35 3 10 mm tissue culture Petri dishes. Neuronal medium was conditioned overnight on cultured glia. The conditioned neuronal medium was supplemented with 1 ng/ml glial cell line-derived neurotrophic factor and 500 lM kynurenate and filter-sterilized before it was added to the neuronal cultures.
| Whole-cell electrophysiological recordings
Spontaneous firing activity of midbrain dopamine neurons was exam- 
| Data analysis
The electrophysiology data was acquired using the ClampEx 10 software package (Axon Instruments, Foster City, CA). The data were analyzed offline using pClamp 10. For all experiments, the data are presented as mean 6 SEM. n denotes the number of neurons for each experiment. Statistical significance was assessed using Student's t test.
Differences were considered significant at p < .05. 3.2 | Administration of doxycycline has no effect on microglial cell numbers
Since some studies have reported a decrease in microglial cell numbers following Dox administration (Sultan, Gebara, & Toni, 2013) we also assessed microglial density in wild type animals treated with either saline or Dox for 7 days. We found that Dox had no effect on microglial cell density or morphology in either location using Iba1 immunolabeling (p < .05, Figure 3 ). 
| HIV-1 tat-induced loss of TH phenotype is not accompanied by microglial activation
We reasoned that if the observed loss of TH phenotype in the SNc were due to neuronal cell death there would be a swift increase in microglial reactivity and morphology, and likely macrophage transformation, as we and others have shown that microglia respond to acute neurotoxicity in this manner (McCann et al., 1996; Streit, & Kreutzberg, 1988) . We carefully analyzed features of microglial morphology in the SNc of experimental and control groups. As shown in Figure 6 , none of the classic characteristics of microglial activation, such as cytoplasmic hypertrophy or cellular hyperplasia (proliferation), were found in the 
| HIV-1 Tat does not change th mRNA expression in the SNc
Since previous literature has suggested that HIV-1 Tat can inhibit the gene expression of TH (Zauli et al., 2000) , we tested the hypothesis that HIV-1 Tat affects Th mRNA levels in the SNc. To address this hypothesis, we performed quantitative reverse transcription polymerase chain reaction (qRT-PCR) on the SNc derived from wild type mice treated daily for 7 days with 0.9% saline, wild type mice treated daily for 7 days with doxycycline (Dox, 100 mg/kg) in 0.9% saline, and GT-tg mice treated daily for 7 days with Dox (100 mg/kg) in 0.9% saline. We measured fold change in Th mRNA expression in the SNc of all experimental groups compared with that of wild type mice treated with 0.9% saline for 7 days. HIV-1 Tat induction with Dox in the GT-tg mice did not change expression of the Th gene as compared with wild type controls treated with saline. These results suggest that the loss of TH phenotype in the SNc occurs at the level of the protein as observed in Figure 4 instead of at the level of gene transcription.
| HIV-1 tat decreased spontaneous firing activity of dopamine neurons
To examine the direct effect of HIV-1 Tat on dopamine transmission we used single neuron recording when Tat (Tat 1-86 , 5 ng) was directly applied into the dopamine neuron via the whole-cell patch pipette (Fog et al., 2006; Gnegy et al., 2004) . To ensure proper identification of dopamine neurons in our recordings we used multiple complementary approaches. The dopaminergic neurons were identified (a) by expression of tyrosine hydroxylase (TH) promoter-driven red fluorescent protein, (b) morphologically by their large cell bodies with broad 2-5 first order processes, (c) electrophysiologically by their well-characterized spontaneous firing frequency of 0.3-4 Hz as described previously (Richardson et al., 2016; Saha et al., 2014; Sambo et al., 2017) . The average input resistance was 320.5 6 22.5 MX; membrane time constant was 832.1 6 46.7 ls; and membrane capacitance was 65.8 6 3.3 pF. Figure 8 shows a representative example of spontaneous spike activity before (D and E) and after application of HIV-1 Tat (5 ng) into the dopamine neuron (F and G). Consistent with previous studies (Grace & Bunney, 1984) , the majority of the recorded dopamine neurons exhibited a mixture of single spikes and burst activity with an underlying "pacemaker-like" periodicity. Tonic irregular single-spike firing occurred at rates of 1-4 spikes per second; bursts of 3-8 spikes occurred at high frequencies of 10-20 Hz with a pause between subsequent bursts.
The resting potential was defined as the baseline voltage at spike threshold. Application of HIV-1 Tat into the neurons gradually reduced the spontaneous firing rate, which was determined from the mean baseline value set as 100% (Figure 8 , p < 0.05, Student's t tests; n 5 5-7).
Since we performed these experiments in the presence of D1 and D2
receptors blockade in the bath solution, these data suggest that upon entry into the dopamine neurons, HIV-1 Tat can directly modulate neuronal activity leading to decreased dopamine transmission.
| D IS C U S S I O N
In this study, we have found that the ratio of microglia to dopamine neurons is smaller in the SNc than in the VTA of wild type C57BL/6J While microglia are present in large numbers in the mouse brain, they are not uniformly distributed (Lawson, Perry, Dri, & Gordon, 1990) . Though the variation in the density of F4/80 immunostained microglia among brain regions has been shown to be greater than fivefold and particularly dense in the basal ganglia, especially the substantia nigra (Lawson et al., 1990) , the ratio of microglia to neurons in each brain region is not well documented. To our knowledge, this is the first study to have examined the ratio of microglia to dopamine neurons in the SNc and VTA. The lower ratio of microglia/TH1 neurons in the SNc underscores diversity of different dopaminergic populations and may explain in part the higher vulnerability of SN versus VTA neurons to loss of TH immunoreactivity, and the differential vulnerability of SNc neurons to the adverse effects of toxins, oxidative stress or cell death in aging or in PD (Choi et al., 2015; Guzman et al., 2010; Macdonald & Monchi, 2011; Teo et al., 2004) . Alterations in the dopaminergic system are thought to be important for understanding subcortical dementia characteristic of HAND (Berger & Arendt, 2000; Koutsilieri et al., 2002; Purohit et al., 2011) .
The loss of TH immunoreactivity in the SNc reported here in GT-tg mice is consistent with a reported loss of dopamine neurons and decreased dopamine levels in the human substantia nigra (Itoh et al., 2000; Obermann et al., 2009; Reyes et al., 1991) , and associated clinical symptoms such as Parkinson-like movement disorders, bradykinesia, tremor or postural instability in HIV patients (Arendt, Maecker, Purrmann, & Homberg, 1994; Navia, Jordan, & Price, 1986 ) even after antiretroviral therapy (Valcour et al., 2008 to what has been observed after axotomy of the nigrostriatal pathway (Hagg, 1998) . Importantly, our data indicate that the reduction in TH1
neurons represents a loss of immunoreactivity rather than true cell loss because we observed neither microglial activation, macrophage formation, or reactive astrogliosis, which would occur if indeed there was acute neuronal death, as in the case of true (canonical) toxicity, or in the case of age-related loss of SN neurons (Beach et al., 2007 ). Since we did not find any changes in Th mRNA expression in the SNc following HIV-1 Tat induction, reduced TH immunostaining may be attributable to a reduction or loss of the rate-limiting enzyme for dopamine synthesis, tyrosine hydroxylase (TH). TH enzymatic activity can increase upon phosphorylation (Lindgren et al., 2002) and further studies will determine if the HIV-1 Tat-induced loss of TH immunoreactivity occurs because of a reduction in the phosphorylation of serine or nonserine residues in the TH protein, or because of an increase in dephosphorylation of TH amino acid residues by protein phosphatases.
In any case, loss of TH and reduced firing activity of dopamine neurons following exposure to Tat imply reduced dopamine production and could thus explain the drop in dopamine levels seen in subjects with HAND (Kumar et al., 2009; Purohit et al., 2011) . Lower levels of dopamine may also affect microglial cell functions as they are known to bear D1 and D2 receptors (Farber et al., 2005) , and could impact their ability to engage in bidirectional communication with dopaminergic neurons.
Lack of microglial activation in the GT-tg bigenic mouse model reported here supports the view that Dox-induced HIV-1 Tat does not trigger an inflammatory response. These results confirm those by others using the same animal model showing that combined Tat induction and morphine exposure, but neither manipulation alone, increased microglial reactivity in the striatum (Bruce-Keller et al., 2008) . However, our results also seemingly stand in contrast to studies reporting mild microglial hypertrophy in GT-tg mice (Paris et al., 2015) , albeit not in the substantia nigra (which was not studied) but in the VTA at marginally increased levels. Such minimal increases in microglial cell size are likely due to morphological differences among individual cells, i.e. minimal hypertrophy that could reflect variations in microglial morphology, which are commonplace and may not be of functional significance.
Although microglial activation has been reported many times in HIV encephalitis, and also after experimental HIV-1 Tat exposure in vivo and in vitro (Liu et al., 2013; Lu et al., 2011) , it is not clear why or how viral infection of microglia would cause the cells to become activated. It seems more likely that microglial function would be impaired by viral entry (as is the case in peripheral lymphocytes), and that neuroinflammation in HIV-infected human brain may be caused by secondary, opportunistic infections, such as toxoplasmosis, or other fungal, viral or bacterial infections commonly seen in these patients (Streit, Xue, Braak, & del Tredici, 2014) . These opportunistic CNS infections occur because of compromised (microglial) immune function. When HIV-1 enters microglia in the CNS, it likely causes their dysfunction rather than activation, as evidenced histopathologically by presence of multinucleated giant cells (MNGCs), a pathognomonic histopathological hallmark feature of HIV infection in human brain (Michaels et al., 1988) . MNGCs have been described in animal models of disease showing dysfunctional, degenerating microglial cells (Fendrick, Xue, & Streit, 2007) .
Previous reports have shown reductions in microglia using staining for Iba1 and Mac-1 antigens in the mouse brain after weeks of doxycycline administration implying that the use of this antibiotic could confound studies of brain inflammation (Lazzarini et al., 2013; Sultan et al., 2013) . We have therefore considered the possibility that 7 days of 100 mg/kg doxycycline administration might affect the number and morphology of microglia and possibly TH immunoreactivity in the SNc.
However, as shown in Figures 2 and 3 , there is no difference in the number and morphology of neurons and microglia in the SNc of wild type mice exposed to 7 days of 100 mg/kg of doxycycline or saline.
These results are consistent with previous reports that 100 mg/kg doxycycline for 14 days had no effect on the number and morphology of microglia (Paris et al., 2014) , and that even higher doses of the doxycycline analog, minocycline, did not inhibit microglial activation after nerve injury (Fendrick, Miller, & Streit, 2005) .
As with all mouse models of human diseases, including HIV-1 infection, there are limitations to the applicability of the GT-tg bigenic model. Perhaps most importantly, there is of course no viral infection and Tat is expressed not in microglia, which are normally targeted by HIV-1 in humans, but instead in astrocytes, and for a much shorter duration. Thus, all findings in this and other models must be interpreted cautiously. However, the fact that we have found a perturbation in dopaminergic neurons, albeit subtle and not as severe as what occurs in human HIV patients, supports the idea that a dopamine deficit may exacerbate progression of HAND/HAD (Purohit et al., 2011) . It also shows utility of this animal model encouraging further research into interactions between microglia and dopaminergic neurons.
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